GLP-1 & aesthetic medicine
Ozempic face treatment: Botox & fillers that work
Millions are losing weight with GLP-1 medications — but many are discovering an unexpected side effect: a hollower, older-looking face. Here's what causes it, what the clinical research shows, and how to fix it.
What is Ozempic face — and why does it happen?
You stepped on the scale and saw the number you worked toward. Then you looked in the mirror and saw something you didn't expect — a face that looked sunken, tired, and older than before you started losing weight.
You're not imagining it. Dermatologists now have a name for it: Ozempic face — the constellation of facial changes that accompany rapid weight loss from GLP-1 medications like semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro), bariatric surgery, or aggressive dieting.
The face isn't a uniform fat layer. It's a complex architecture of distinct fat compartments, ligaments, muscles, and skin. When weight is lost rapidly, those compartments deflate — but the overlying skin doesn't retract at the same pace. A systematic review published in the Aesthetic Surgery Journal Open Forum documented significant reductions in facial fat compartments including the temporal and cheek fat pads, with patients appearing meaningfully older following massive weight loss. (Jafar et al., 2024)
A separate study found that blinded evaluators consistently rated post-weight-loss photographs as older and less attractive compared to pre-weight-loss images of the same patients. (Hess et al., 2015)
GLP-1 medications may also directly affect the skin beyond fat loss — a comprehensive review confirmed these drugs can contribute to dermal thinning, decreased skin elasticity, and accelerated skin aging independent of weight change. (Eaton et al., Diseases, 2025)
Volume-driven aging
Hollowness, sunken temples, deflated cheeks, and deepened folds caused by fat pad deflation — visible at rest, independent of muscle movement.
Movement-driven aging
Dynamic wrinkles that look deeper on skin that no longer has the fat cushion beneath to soften repeated muscle contractions.
Two types of facial aging, two targeted treatments
Botox for dynamic wrinkles after weight loss
Forehead lines, frown lines, and crow's feet are caused by muscles repeatedly contracting beneath the skin. After weight loss, those lines look deeper — because the fat that once cushioned them from below is gone. Botulinum toxin (Botox, Dysport, Xeomin) temporarily relaxes the target muscles, stopping the mechanical force that engraves lines deeper over time. It doesn't restore volume — but it prevents ongoing muscle activity from worsening the damage while other treatments address structural loss.
A Global Aesthetics Consensus review confirmed an evidence-based shift toward combination neuromodulator and filler treatment to address both dynamic and structural facial concerns simultaneously. (Liew et al., PRS, 2016)
Hyaluronic acid fillers for facial volume loss
Hollow temples, sunken under-eyes, flat cheeks, deepened nasolabial folds — these are structural deficits, not muscle problems. They exist because the fat scaffolding beneath the skin has been lost. Hyaluronic acid (HA) fillers — Restylane, Belotero, Teosyal, Hyabell — physically replace that lost structural volume in multiple viscosities: thicker, more cohesive gels for deep cheek and temple volumisation; softer, more pliable formulations for delicate areas like the tear trough.
A whole-face HA filler approach has been shown to address age-related volume changes across all facial zones when products are matched to the anatomical needs of each region. (Lipko-Godlewska et al., CCID, 2021)
Why Botox and fillers work better together
Combining both produces results neither achieves alone. Botox reduces the muscle tension that would otherwise degrade filler placement over time, while fillers restore the structural foundation that makes Botox results look natural rather than flat. A Global Aesthetics Consensus concluded that combination treatment is now the standard of care — shifting from single-modality rejuvenation toward comprehensive facial harmonisation. (De Boulle et al., PRS, 2016)
How to sequence the treatments
Fillers first, Botox second
Fillers are placed into deep tissue planes first. Botox is administered last, protecting filler precision — Botox injected first causes swelling that can distort placement. A published single-visit pan-facial approach confirmed the safety and practicality of this sequence. (Chao, PRS Global Open, 2018)
Botox first, fillers two weeks later
Botox is done first. After two weeks — once muscles have fully relaxed — fillers are placed into a stable, low-tension environment, reducing migration risk in high-movement areas. (Hall, Plastic Surgical Nursing, 2024)
Zone by zone: where Ozempic face shows up
Individualized treatment planning across anatomical zones — based on each patient's specific pattern of volume loss and muscular activity — is essential for natural-looking results. (Farolch-Prats & Nome-Chamorro, Aesthetic Plastic Surgery, 2019)
One of the first areas to hollow, creating a skeletal appearance. HA filler rebuilds lateral facial fullness and restores a naturally rounded upper face.
The structural core most dramatically affected by fat pad loss. Deep-plane filler lifts the entire midface framework, indirectly softening nasolabial folds.
Periorbital hollowing creates persistent dark shadows. HA filler along the orbital rim reshapes the 3D periorbital complex and reduces hollow eyes.
Botox softens a downturned mouth and chin dimpling. Marionette lines, accordion lines, and nasolabial folds are refined with filler.
Why GLP-1 patients need a different approach
Patients on GLP-1 medications aren't standard cosmetic patients. Simple spot-filling under-delivers because their facial aging is multi-layered — involving fat loss, skin quality changes, and potentially direct drug-related dermal effects all at once. A case series demonstrated that patients treated with a staged injectable protocol showed dramatic improvements in quality of life and psychological function. (Lee & Rullan, Cureus, 2023)
The recommended approach is layered and staged over 6–12 months:
Before adding volume, the dermal scaffold needs rebuilding. Sculptra (PLLA), Radiesse (CaHA), and AestheFill (PDLLA) don't provide immediate filling — they trigger the body's own collagen production over several months, creating a biological foundation that makes subsequent HA filler more effective and longer-lasting. PLLA has extensive published evidence confirming collagen neogenesis through fibroblast stimulation. (Avelar et al., JCD, 2025) CaHA has demonstrated increases in collagen, elastin, vasculature, and fibroblast populations post-injection. (Aguilera et al., ASJ, 2024)
Once the collagen scaffold has been partially rebuilt, targeted HA filler is placed for structural volumisation — cheeks, temples, jawline, tear trough — with results that last longer on a biostimulated foundation.
Volume restoration alone doesn't address the thin, crepey, dehydrated skin GLP-1 patients frequently present with. Rejuran (polynucleotides) stimulates fibroblast activity and promotes tissue repair from within — a systematic review confirmed improvements in skin texture, elasticity, and hydration. (Christopoulos et al., JCD, 2024) Skin boosters restore internal hydration and surface elasticity without adding localised volume. (Kim et al., Seminars in Plastic Surgery, 2024)
Important: Avoid overcorrecting early. As weight stabilises or GLP-1 doses are adjusted, some facial volume may partially return. Aggressive early filling can result in an overfilled appearance. Reassess at each interval and treat in stages.
How to fix Ozempic face: common questions answered
What is Ozempic face?
The term dermatologists use to describe facial volume loss, skin laxity, and accelerated aging that can occur with rapid weight loss — particularly in patients using GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro). The face loses fat compartments faster than the skin can retract, resulting in a hollower, older-looking appearance.
Can Botox fix Ozempic face on its own?
No. Botox addresses dynamic wrinkles — forehead lines, frown lines, and crow's feet — that appear more prominent after fat loss, but it doesn't restore lost volume. Full correction combines Botox with hyaluronic acid fillers and, for GLP-1 patients, biostimulators like Sculptra or Radiesse.
How many syringes of filler does Ozempic face require?
More than a standard cosmetic patient. Initial correction for significant GLP-1-associated volume loss typically requires a staged approach — often 4–8 syringes distributed across multiple sessions over 6–12 months — followed by annual maintenance. Volume needs vary significantly based on extent of weight loss, age, and starting facial anatomy.
Do fillers last as long in GLP-1 patients?
Results can be shorter-lived if filler is placed without first rebuilding the collagen scaffold. Using biostimulators like Sculptra or Radiesse before HA filler creates a more durable foundation and improves filler longevity and overall outcomes.
Is it safe to get fillers while still on Ozempic or Mounjaro?
Generally yes, but treatment planning should account for ongoing weight changes. If a patient is still actively losing weight, many practitioners prefer to begin with biostimulators — which improve skin quality without committing to fixed structural volume — until weight has stabilised.
How long does Ozempic face treatment take to work?
Botox results appear within 3–7 days, peaking at two weeks. HA filler results are immediate, with final appearance visible after swelling resolves at 2–4 weeks. Biostimulators like Sculptra work gradually — collagen builds over 3–6 months, with full results at 6–9 months. A complete Ozempic face correction protocol typically spans 6–12 months.
The bottom line
The tools to address post-weight-loss facial aging are better than they've ever been — and the clinical evidence guiding their use is growing rapidly.
Botox stops the dynamic wrinkles that weight loss makes more prominent. Hyaluronic acid fillers restore the structural volume that disappears with fat loss. Biostimulators like Sculptra, Radiesse, and AestheFill rebuild the collagen scaffold from within. Rejuran and skin boosters restore the surface quality that volume restoration alone cannot address.
For patients who have worked hard to achieve significant weight loss — with or without GLP-1 medications — the right injectable protocol allows the face to reflect the health and vitality that the rest of the body now embodies. The key is finding a practitioner with specific experience in this patient population. The clinical picture of GLP-1-associated facial aging is meaningfully different from standard cosmetic aging — and it demands a different approach entirely.
Ready to restore your facial volume?
Consult with our team to build a personalised Ozempic face treatment plan tailored to your goals, timeline, and budget.
Book a consultationThis article is for informational purposes only and does not constitute medical advice. Always consult a qualified, licensed aesthetic medicine physician for personalised treatment recommendations.
SEO: Primary keyword: ozempic face treatment · Secondary keywords: how to fix Ozempic face, Botox for weight loss face, hyaluronic acid fillers facial volume loss, GLP-1 facial aging · URL slug: /ozempic-face-treatment-botox-fillers
